SP 5186

a cysteine-containing nitric oxide donor that attenuates postischemic myocardial injury; a prodrug of SP/W 3672; structure in first source

Also Known As:

N-(3-nitratopivaloyl)-S-(N'-acetylglycyl)-L-cysteine ethylester; SP W 5186; SP-W-5186; W-5186

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Myocardial Reperfusion Injury 11/01/1998 - "The effects of SP/W-5186, a cysteine-containing nitric oxide (.NO) donor, on myocardial reperfusion injury were studied in a rabbit ischemia (45 min) and reperfusion (180 min) model. "
2.	Reperfusion Injury 11/01/1998 - "These results demonstrate that NO released from SP/W-5186 significantly protected myocardial tissue from reperfusion injury. "
3.	Ischemia 11/01/1998 - "The effects of SP/W-5186, a cysteine-containing nitric oxide (.NO) donor, on myocardial reperfusion injury were studied in a rabbit ischemia (45 min) and reperfusion (180 min) model. "

1.	Nitric Oxide (Nitrogen Monoxide)
2.	Cysteine (L-Cysteine)